References
Rahkonen T, et al. (2003) Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 74(6):720–724
McKeith IG, et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47(5):1113–1124
Kornhuber J, Weller M (1994) Neuroleptic malignant syndrome. Curr Opin Neurol 7(4):353–357
Ballard C, et al. (1998) Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer’s disease. Lancet 351 (9108):1032–1033
Minoshima S, et al. (2001) Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50(3):358–365
Colloby SJ, et al. (2002) A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer’s disease using statistical parametric mapping. Eur J Nucl Med 29(5):615–622
Donnemiller E, et al. (1997) Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123Ibeta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med 24(3):320–325
Kanemaru K, Kameda N, Yamanouchi H (2000) Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies. Neurology 54(9):1875–1876
Tschampa HJ, et al. (2001) Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies. Neurology 56(4):576
Mizuta E, et al. (1993) Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period. Neurology 43(5):1048–1049
Ochi G, et al. (1995) Neuroleptic malignant- like syndrome: a complication of acute organophosphate poisoning. Can J Anaesth 42(11):1027–1030
Konagaya M, et al. (1997) Neuroleptic malignant syndrome-like condition in multiple system atrophy. J Neurol Neurosurg Psychiatry 63(1):120–121
Hayashi K, et al. (1993) Clinical features of neuroleptic malignant syndrome in basal ganglia disease. Spontaneous presentation in a patient with Hallervorden-Spatz disease in the absence of neuroleptic drugs. Anaesthesia 48(6):499–502
Piggott MA, et al. (1998) Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson’s disease. Biol Psychiatry 44(8):765–774
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weber, K.E., Linker, R.A., Lorenz, R. et al. Recurrent spontaneous ”neuroleptic malignant syndrome” in the absence of neuroleptic medication in probable dementia with Lewy bodies. J Neurol 252, 1122–1124 (2005). https://doi.org/10.1007/s00415-005-0804-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0804-1